These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9920446

  • 1. Melanocortin mediated inhibition of feeding behavior in rats.
    Murphy B, Nunes CN, Ronan JJ, Harper CM, Beall MJ, Hanaway M, Fairhurst AM, Van der Ploeg LH, MacIntyre DE, Mellin TN.
    Neuropeptides; 1998 Dec; 32(6):491-7. PubMed ID: 9920446
    [Abstract] [Full Text] [Related]

  • 2. Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats.
    Roseberry AG.
    Psychopharmacology (Berl); 2013 Mar; 226(1):25-34. PubMed ID: 23010797
    [Abstract] [Full Text] [Related]

  • 3. Feeding and behavioural effects of central administration of the melanocortin 3/4-R antagonist SHU9119 in obese and lean Siberian hamsters.
    Schuhler S, Horan TL, Hastings MH, Mercer JG, Morgan PJ, Ebling FJ.
    Behav Brain Res; 2004 Jul 09; 152(2):177-85. PubMed ID: 15196785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus.
    Sutton GM, Duos B, Patterson LM, Berthoud HR.
    Endocrinology; 2005 Sep 09; 146(9):3739-47. PubMed ID: 15961554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.
    Endocrinology; 2000 Dec 09; 141(12):4419-27. PubMed ID: 11108250
    [Abstract] [Full Text] [Related]

  • 9. Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.
    Hwa JJ, Ghibaudi L, Gao J, Parker EM.
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug 09; 281(2):R444-51. PubMed ID: 11448846
    [Abstract] [Full Text] [Related]

  • 10. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats.
    Polidori C, Geary N, Massi M.
    Peptides; 2006 Jan 09; 27(1):144-9. PubMed ID: 16198024
    [Abstract] [Full Text] [Related]

  • 11. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition.
    Azzara AV, Sokolnicki JP, Schwartz GJ.
    Physiol Behav; 2002 Nov 09; 77(2-3):411-6. PubMed ID: 12419417
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats.
    Cabeza de Vaca S, Kim GY, Carr KD.
    Psychopharmacology (Berl); 2002 Apr 09; 161(1):77-85. PubMed ID: 11967634
    [Abstract] [Full Text] [Related]

  • 14. Responsivity to NPY and melanocortins in obese OLETF rats lacking CCK-A receptors.
    Moran TH, Lee P, Ladenheim EE, Schwartz GJ.
    Physiol Behav; 2002 Mar 09; 75(3):397-402. PubMed ID: 11897267
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paraventricular hypothalamic alpha-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects.
    Wirth MM, Olszewski PK, Yu C, Levine AS, Giraudo SQ.
    Peptides; 2001 Jan 09; 22(1):129-34. PubMed ID: 11179607
    [Abstract] [Full Text] [Related]

  • 18. Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.
    Beckman TR, Shi Q, Levine AS, Billington CJ.
    Physiol Behav; 2009 Mar 23; 96(4-5):568-73. PubMed ID: 19136019
    [Abstract] [Full Text] [Related]

  • 19. Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats.
    Starowicz K, Przewlocki R, Gispen WH, Przewlocka B.
    Neuroreport; 2002 Dec 20; 13(18):2447-52. PubMed ID: 12499847
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.